東和薬品株式会社 · TOWA PHARMACEUTICAL CO., LTD.
Last · Tokyo¥3615.00+25.00 (+0.70%)close · yahoo · 15h ago
Market cap¥178.0B49.2M sh
P/E · TTM21.5fwd 12.3 · eps 167.94
Beta-0.04vs S&P 500
Div yield2.19%annual · TTM
52w range
¥2764.00¥4490.00
Volume16.5Ksession
| Revenue | ¥273.7B |
|---|---|
| Operating income | ¥23.1B |
| Net income | ¥5.3B |
| Free cash flow | ¥10.1B |
| Operating margin | 8.4% |
| Net margin | 1.9% |
| Return on equity | 3.3% |
| Period | 2026 |
Loading chart…
OpenFilings analyst
Our analyst
From latest ANNUAL · 2024-07-10
- Cash Runway Low
Red flags
- Cash Runway Low — Cash runway ~1.1 years
Upcoming earnings
7:30 AM UTC+1
Period
Sep 2026
Est. EPS
$101.18
Est. revenue
70.9B
Documents
FormReporting forFiledFlags